American Century Companies’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Buy |
40,780
+776
| +2% | +$5.87K | ﹤0.01% | 2658 |
|
|
2025
Q1 | $221K | Buy |
40,004
+3,042
| +8% | +$16.8K | ﹤0.01% | 2741 |
|
|
2024
Q4 | $213K | Buy |
36,962
+3,501
| +10% | +$20.1K | ﹤0.01% | 2773 |
|
|
2024
Q3 | $347K | Buy |
33,461
+5,569
| +20% | +$57.7K | ﹤0.01% | 2589 |
|
|
2024
Q2 | $362K | Buy |
27,892
+7,287
| +35% | +$94.5K | ﹤0.01% | 2558 |
|
|
2024
Q1 | $360K | Buy |
20,605
+9,975
| +94% | +$174K | ﹤0.01% | 2566 |
|
|
2023
Q4 | $100K | Buy |
+10,630
| New | +$100K | ﹤0.01% | 2813 |
|
|
2020
Q2 | – | Sell |
-18,333
| Closed | -$943K | – | 1749 |
|
|
2020
Q1 | $943K | Buy |
18,333
+93
| +0.5% | +$4.78K | ﹤0.01% | 999 |
|
|
2019
Q4 | $1.13M | Sell |
18,240
-27,264
| -60% | -$1.68M | ﹤0.01% | 1078 |
|
|
2019
Q3 | $2.73M | Buy |
+45,504
| New | +$2.73M | ﹤0.01% | 924 |
|
|
2018
Q4 | – | Sell |
-37,606
| Closed | -$3.21M | – | 1263 |
|
|
2018
Q3 | $3.21M | Buy |
37,606
+5,178
| +16% | +$443K | ﹤0.01% | 943 |
|
|
2018
Q2 | $3.76M | Buy |
+32,428
| New | +$3.76M | ﹤0.01% | 906 |
|
|
2016
Q1 | – | Sell |
-79,158
| Closed | -$2.61M | – | 1316 |
|
|
2015
Q4 | $2.61M | Buy |
79,158
+234
| +0.3% | +$7.73K | ﹤0.01% | 981 |
|
|
2015
Q3 | $2.85M | Buy |
78,924
+51,124
| +184% | +$1.85M | ﹤0.01% | 969 |
|
|
2015
Q2 | $1.21M | Buy |
+27,800
| New | +$1.21M | ﹤0.01% | 1119 |
|